NCT06203912
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT06203912
NCT05653271
NCT06694779
NCT07673666
NCT04168788
NCT04975698
NCT07154901
NCT05455931
NCT01209871
NCT04292626